Nuvectis Total Other Income Expense Net vs Income Before Tax Analysis

NVCT Stock  USD 5.10  0.20  4.08%   
Nuvectis Pharma financial indicator trend analysis is infinitely more than just investigating Nuvectis Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nuvectis Pharma is a good investment. Please check the relationship between Nuvectis Pharma Total Other Income Expense Net and its Income Before Tax accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.

Total Other Income Expense Net vs Income Before Tax

Total Other Income Expense Net vs Income Before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nuvectis Pharma Total Other Income Expense Net account and Income Before Tax. At this time, the significance of the direction appears to have pay attention.
The correlation between Nuvectis Pharma's Total Other Income Expense Net and Income Before Tax is -0.83. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Nuvectis Pharma, assuming nothing else is changed. The correlation between historical values of Nuvectis Pharma's Total Other Income Expense Net and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Nuvectis Pharma are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Total Other Income Expense Net i.e., Nuvectis Pharma's Total Other Income Expense Net and Income Before Tax go up and down completely randomly.

Correlation Coefficient

-0.83
Relationship DirectionNegative 
Relationship StrengthSignificant

Total Other Income Expense Net

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Nuvectis Pharma income statement and is an important metric when analyzing Nuvectis Pharma profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.
Most indicators from Nuvectis Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nuvectis Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.Enterprise Value is likely to gain to about 116.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.6 M in 2024.
 2010 2022 2023 2024 (projected)
Interest Income4K149K475K498.8K
Net Interest Income4K149K475K498.8K

Nuvectis Pharma fundamental ratios Correlations

0.950.960.880.88-0.90.971.0-0.971.00.67-0.010.550.430.881.00.98-0.97-0.56-0.560.97-0.560.69-0.560.66
0.951.00.730.77-0.950.990.96-0.940.960.760.210.380.640.730.950.98-0.93-0.62-0.620.97-0.620.78-0.620.74
0.961.00.740.77-0.941.00.96-0.940.960.720.220.440.640.740.960.99-0.94-0.6-0.60.96-0.60.74-0.60.71
0.880.730.740.99-0.770.740.88-0.90.880.64-0.450.420.031.00.880.79-0.9-0.64-0.640.86-0.640.63-0.640.67
0.880.770.770.99-0.840.770.88-0.920.880.75-0.410.310.110.990.880.8-0.92-0.73-0.730.9-0.730.73-0.730.77
-0.9-0.95-0.94-0.77-0.84-0.92-0.90.96-0.9-0.88-0.1-0.18-0.61-0.77-0.89-0.910.950.830.83-0.960.83-0.860.83-0.9
0.970.991.00.740.77-0.920.97-0.950.970.670.240.50.640.740.971.0-0.94-0.57-0.570.94-0.570.68-0.570.66
1.00.960.960.880.88-0.90.97-0.971.00.68-0.010.540.430.881.00.98-0.97-0.56-0.560.97-0.560.7-0.560.66
-0.97-0.94-0.94-0.9-0.920.96-0.95-0.97-0.97-0.760.03-0.41-0.46-0.9-0.97-0.951.00.740.74-0.970.74-0.750.74-0.78
1.00.960.960.880.88-0.90.971.0-0.970.68-0.010.540.430.881.00.98-0.97-0.56-0.560.97-0.560.7-0.560.66
0.670.760.720.640.75-0.880.670.68-0.760.68-0.13-0.250.380.640.670.64-0.75-0.87-0.870.83-0.870.99-0.870.98
-0.010.210.22-0.45-0.41-0.10.24-0.010.03-0.01-0.130.130.84-0.45-0.010.170.030.120.12-0.040.12-0.120.12-0.13
0.550.380.440.420.31-0.180.50.54-0.410.54-0.250.130.130.420.550.56-0.430.230.230.330.23-0.230.23-0.24
0.430.640.640.030.11-0.610.640.43-0.460.430.380.840.130.030.430.58-0.46-0.4-0.40.44-0.40.37-0.40.41
0.880.730.741.00.99-0.770.740.88-0.90.880.64-0.450.420.030.880.79-0.9-0.64-0.640.86-0.640.63-0.640.67
1.00.950.960.880.88-0.890.971.0-0.971.00.67-0.010.550.430.880.98-0.97-0.56-0.560.97-0.560.69-0.560.66
0.980.980.990.790.8-0.911.00.98-0.950.980.640.170.560.580.790.98-0.95-0.55-0.550.95-0.550.65-0.550.63
-0.97-0.93-0.94-0.9-0.920.95-0.94-0.971.0-0.97-0.750.03-0.43-0.46-0.9-0.97-0.950.740.74-0.960.74-0.730.74-0.78
-0.56-0.62-0.6-0.64-0.730.83-0.57-0.560.74-0.56-0.870.120.23-0.4-0.64-0.56-0.550.741.0-0.691.0-0.81.0-0.95
-0.56-0.62-0.6-0.64-0.730.83-0.57-0.560.74-0.56-0.870.120.23-0.4-0.64-0.56-0.550.741.0-0.691.0-0.81.0-0.95
0.970.970.960.860.9-0.960.940.97-0.970.970.83-0.040.330.440.860.970.95-0.96-0.69-0.69-0.690.84-0.690.81
-0.56-0.62-0.6-0.64-0.730.83-0.57-0.560.74-0.56-0.870.120.23-0.4-0.64-0.56-0.550.741.01.0-0.69-0.81.0-0.95
0.690.780.740.630.73-0.860.680.7-0.750.70.99-0.12-0.230.370.630.690.65-0.73-0.8-0.80.84-0.8-0.80.95
-0.56-0.62-0.6-0.64-0.730.83-0.57-0.560.74-0.56-0.870.120.23-0.4-0.64-0.56-0.550.741.01.0-0.691.0-0.8-0.95
0.660.740.710.670.77-0.90.660.66-0.780.660.98-0.13-0.240.410.670.660.63-0.78-0.95-0.950.81-0.950.95-0.95
Click cells to compare fundamentals

Nuvectis Pharma Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nuvectis Stock Analysis

When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.